Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapy

Abstract

Objectives

This study investigated postpartum bone mineral density (BMD) in patients with systemic lupus erythematosus (SLE) receiving long-term glucocorticoid (GC) therapy, assessed risk factors for decreased postpartum BMD, and evaluated change of BMD after postpartum initiation or restarting of osteoporosis drugs.

Methods

We retrospectively examined 30 SLE patients who gave birth and 31 non-pregnant SLE patients. In the postpartum SLE patients, BMD was measured after delivery and 1 year later. Multivariate analyses were performed to assess risk factors for decreased BMD in postpartum SLE patients.

Results

Patient age at pregnancy was 34.5 ± 4.5 years, and SLE duration was 9.7 ± 6.0 years. The mean prednisolone dose was 9.7 ± 3.2 mg/day. Body mass index (BMI) was 21.6 ± 2.2 kg/m², with 13 women (43%) experiencing their first delivery. Postpartum BMD was 1.080 ± 0.120 g/cm² in the lumbar spine and 0.834 ± 0.109 g/cm² in the total hip. Bone loss occurred in six patients (21%) in the lumbar spine and 11 patients (37%) in the total hip. Postpartum lumbar spine BMD was significantly reduced compared to that in the non-pregnant group (1.143 ± 0.120 g/cm², p = 0.048). Multivariate analysis identified gestational age and low BMI before pregnancy as risk factors for hip bone loss.

Conclusion

Postpartum BMD significantly decrease in SLE patients receiving long-term GC, and low BMI before pregnancy was a risk factor for the decrease. Preconception care to prevent osteoporosis and that regularly monitors BMD after delivery are needed.

Keywords

Body mass index glucocorticoid osteoporosis preconception care systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Kiriakidou

Ching

. Systemic lupus erythematosus. Ann Intern Med 2020; 172: ITC81–ITC96.

Bultink

IEM

. Osteoporosis and fractures in systemic lupus erythematosus. Arthritis Care Res 2012; 64: 2–8.

Yee

C-S

Crabtree

Skan

, et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 111–113.

Wang

Yan

Liu

, et al. Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int 2016; 27: 1413–1423.

Di Munno

Mazzantini

Sedie

Mosca

Bombardieri

. Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus 2004; 13: 724–730.

Adami

Saag

. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int 2019; 30: 1145–1156.

Van Staa

Laan

Barton

IP.

Cohen

Reid

Cooper

. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 2003; 48: 3224–3229.

Buckley

Guyatt

Fink

, et al. 2017 american college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol 2017; 69: 1521–1537.

Suzuki

Nawata

Soen

, et al. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese society for bone and mineral research: 2014 update. J Bone Mineral Metab 2014; 32: 337–350.

10.

Hardy

Palmer

Morton

Muir

Powell

. Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology 1999; 38: 559–563.

11.

Arnaud

Tektonidou

. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology (Oxford, England) 2020; 59(Suppl5): v29–v38.

12.

Pitkin

. Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 1985; 151: 99–109.

13.

Kovacs

Ralston

. Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 2015; 26: 2223–2241.

14.

Hochberg

. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

15.

Bombardier

Gladman

Urowitz

, et al. Derivation of the sledai. a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640.

16.

van Staa

. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcified Tissue Int 2006; 79: 129–137.

17.

Adami

Saag

. Glucocorticoid-induced osteoporosis update. Curr Opin Rheumatol 2019; 31: 388–393.

18.

Clowes

Peel

Eastell

. Glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2001; 13: 326–332.

19.

Ishida

Yoshida

Kimura

, et al. Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study. Lupus 2018; 27: 1636–1643.

20.

Sowers

Corton

Shapiro

, et al. Changes in bone density with lactation. JAMA: J Am Med Assoc 1993; 269: 3130–3135.

21.

Kalkwarf

SpeckerSpecker

. Bone mineral changes during pregnancy and lactation. Endocrine 2002; 17: 49–54.

22.

Yoshikata

Tsugawa

Watanabe

, et al. 25-Hydroxyvitamin D profiles and maternal bone mass during pregnancy and lactation in Japanese women. J Bone Mineral Metab 2020; 38: 99–108.

23.

Kurabayashi

Nagata

Takeyama

Matsushita

Tanaka

. Bone mineral density measurement in puerperal women as a predictor of persistent osteopenia. J Bone Mineral Metab 2009; 27: 205–212.

24.

Møller

Við Streym

Mosekilde

Rejnmark

. Changes in bone mineral density and body composition during pregnancy and postpartum. a controlled cohort study. Osteoporos Int 2012; 23: 1213–1223.

25.

Kurabayashi

Nagai

Morikawa

Kamimura

Yanase

Hayashi

. Prevalence of osteoporosis and osteopenia assessed by densitometry in Japanese puerperal women. J Obstet Gynaecol Res 2021; 47: 1388–1396.

26.

Cross

Hillman

Allen

Krause

. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. J Bone Mineral Research : The Official Journal Am Soc Bone Mineral Res 1995; 10: 1312–1320.

27.

Sowers

Zhang

Hollis

, et al. Role of calciotrophic hormones in calcium mobilization of lactation. Am J Clin Nutr 1998; 67: 284–291.

28.

Kovacs

Kronenberg

. Maternal-Fetal calcium and bone metabolism during pregnancy, puerperium, and lactation*. Endocr Rev 1997; 18: 832–872.

29.

Ó Breasail

Prentice

Ward

. Pregnancy‐Related bone mineral and microarchitecture changes in women aged 30 to 45 years. J Bone Mineral Res 2020; 35: 1253–1262.

30.

Capozzi

Scambia

Lello

. Bone metabolism in pregnancy and lactation. Minerva Obstetrics Gynecology 2021; 73: 697–703.

31.

Moyer

Chakravarty

. Management of pregnancy in lupus. Rheum Dis Clin North America 2021; 47: 441–455.

32.

Chen

Zhao

Zuo

. Unfractionated heparin promotes osteoclast formation in vitro by inhibiting osteoprotegerin activity. Int J Mol Sci 2016; 17: 613.

33.

Signorelli

Scuto

Marino

Giusti

Xourafa

Gaudio

. Anticoagulants and osteoporosis. Int J Mol Sci 2019; 20: 5275.

34.

Andreoli

Bertsias

Agmon-Levin

, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017; 76: 476–485.

35.

Lang

Boyle

Fitzgerald

, et al. Optimizing preconception health in women of reproductive age. Minerva Ginecologica 2018; 70: 99–119.

36.

Teng

YKO

Bredewold

EOW

Rabelink

, et al. An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus. Rheumatology 2018; 57: 1707–1720.

37.

Mori

Baba

Kogure

, et al. Assessment of the risk of low bone mineral density in premenopausal Japanese female patients with systemic lupus erythematosus. J Orthopaedics 2018; 15: 89–93.

38.

Furukawa

Kiyohara

Tsukamoto

, et al. Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. Rheumatol Int 2011; 31: 365–376.

39.

Otsuka

Tabata

Someya

Tamura

. Trends in the prevalence of underweight in women across generations in Japan. J Bone Mineral Metab 2021; 39: 719–720.

40.

Kojima

Douchi

Kosha

Nagata

. Cross-sectional study of the effects of parturition and lactation on bone mineral density later in life. Maturitas 2002; 41: 203–209.